文献速递免疫规划

MMR疫苗接种后风疹体液免疫应答的持久性

Durability of humoral immune responses to rubella following MMR vaccination.
PubMed 文献 · Vaccine · 2020-11-12

本研究在98名健康青少年和年轻成人中,于接种两剂MMR-II®疫苗后约7年和约17年两个时间点,评估风疹病毒特异性体液免疫的持久性。结果显示风疹特异性IgG抗体滴度、中和抗体滴度和记忆B细胞应答随时间下降,但降幅相对温和,且抗体滴度仍远高于目前公认的保护性免疫阈值。

要点

  • 接种两剂MMR-II®疫苗后约17年,风疹抗体仍高于保护阈值。
  • 风疹特异性记忆B细胞应答在男性中下降幅度大于女性。
  • 建议明确基于中和抗体滴度和记忆B细胞ELISpot应答的保护相关指标。

核心结论

  • 接种MMR-II®疫苗后风疹特异性体液免疫随时间下降,但受试者抗体滴度仍远高于目前公认的保护性免疫阈值。

研究设计与样本

  • 纵向研究,纳入98名健康青少年和年轻成人,在接种两剂MMR-II®疫苗后约7年和约17年两个时间点评估风疹病毒特异性体液免疫。

主要发现

  • 风疹特异性IgG抗体滴度、中和抗体滴度和记忆B细胞应答随接种后时间延长而下降,但降幅相对温和。
  • 记忆B细胞应答在男性中的下降幅度大于女性。

关键数值与推荐

  • 受试者抗体滴度仍远高于目前公认的保护性免疫阈值。
  • 基于中和抗体滴度和记忆B细胞ELISpot应答的临床保护相关指标尚待明确。

临床怎么用

  • 对于接种两剂MMR-II®疫苗的青少年和年轻成人,风疹体液免疫虽随时间下降但仍高于保护阈值,可据此评估免疫持久性。

局限性

  • 原文未报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: While administration of the measles-mumps-rubella (MMR-II®) vaccine has been effective at preventing rubella infection in the United States, the durability of humoral immunity to the rubella component of MMR vaccine has not been widely studied among older adolescents and adults. METHODS: In this longitudinal study, we sought to assess the durability of rubella virus (RV)-specific humoral immunity in a healthy population (n = 98) of adolescents and young adults at two timepoints: ~7 and ~17 years after two doses of MMR-II® vaccination. Levels of circulating antibodies specific to RV were measured by ELISA and an immune-colorimetric neutralization assay. RV-specific memory B cell responses were also measured by ELISpot. RESULTS: Rubella-specific IgG antibody titers, neutralizing antibody titers, and memory B cell responses declined with increasing time since vaccination; however, these decreases were relatively moderate. Memory B cell responses exhibited a greater decline in men compared to women. CONCLUSIONS: Collectively, rubella-specific humoral immunity declines following vaccination, although subjects' antibody titers remain well above the currently recognized threshold for protective immunity. Clinical correlates of protection based on neutralizing antibody titer and memory B cell ELISpot response should be defined.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Crooke SN, Riggenbach MM, Ovsyannikova IG, et al. Durability of humoral immune responses to rubella following MMR vaccination. Vaccine. 2020. PMID: 33190948. doi:10.1016/j.vaccine.2020.10.076

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。